Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
Arezoo Hosseini, Tohid Gharibi, Faroogh Marofi, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 9, pp. 5903-5924
Closed Access | Times Cited: 75

Showing 26-50 of 75 citing articles:

EGCG Inhibits Adipose-Derived Mesenchymal Stem Cells Differentiation into Adipocytes and Prevents a STAT3-Mediated Paracrine Oncogenic Control of Triple-Negative Breast Cancer Cell Invasive Phenotype
Narjara González Suárez, Sahily Rodriguez Torres, Amira Ouanouki, et al.
Molecules (2021) Vol. 26, Iss. 6, pp. 1506-1506
Open Access | Times Cited: 32
Effect of janus kinase inhibitors and methotrexate combination on malignancy in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials
Vinod Solipuram, Akhila Mohan, Roshniben Patel, et al.
Autoimmunity Highlights (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Common molecular pathways targeted by nintedanib in cancer and IPF: A bioinformatic study
Claudia Landi, Alfonso Carleo, Lorenza Vantaggiato, et al.
Pulmonary Pharmacology & Therapeutics (2020) Vol. 64, pp. 101941-101941
Closed Access | Times Cited: 30
Design, synthesis, and biological evaluation of 2,4-diamino pyrimidine derivatives as potent FAK inhibitors with anti-cancer and anti-angiogenesis activities
Shan Wang, Rong‐Hong Zhang, Hong Zhang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113573-113573
Closed Access | Times Cited: 25
MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells
Souad Djediai, Narjara González Suárez, Layal El Cheikh-Hussein, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13006-13006
Open Access | Times Cited: 25
Ruxolitinib attenuates experimental autoimmune encephalomyelitis (EAE) development as animal models of multiple sclerosis (MS)
Arezoo Hosseini, Tohid Gharibi, Adel Mohammadzadeh, et al.
Life Sciences (2021) Vol. 276, pp. 119395-119395
Closed Access | Times Cited: 23
Development and Therapeutic Implications of Tyrosine Kinase 2 Inhibitors
Kuojun Zhang, Ke Ye, He Tang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4378-4416
Closed Access | Times Cited: 10
Baricitinib protects ICIs-related myocarditis by targeting JAK1/STAT3 to regulate Macrophage polarization
Xuejun Wang, Jiahui Chen, Yihui Shen, et al.
Cytokine (2024) Vol. 179, pp. 156620-156620
Closed Access | Times Cited: 3
Janus Kinase Inhibitors and Non-Melanoma Skin Cancer
Charlotte Greif, Divya Srivastava, Rajiv I. Nijhawan
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 2
Closed Access | Times Cited: 22
Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis
Y. Lei, Xiaodan He, Han Huang, et al.
Clinical & Translational Oncology (2021) Vol. 24, Iss. 1, pp. 34-47
Closed Access | Times Cited: 20
Computer-Aided Drug Design of Novel Derivatives of 2-Amino-7,9-dihydro-8H-purin-8-one as Potent Pan-Janus JAK3 Inhibitors
Abdelmoujoud Faris, Ibrahim M. Ibrahim, Omkulthom Al Kamaly, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5914-5914
Open Access | Times Cited: 8
Computational insights into rational design and virtual screening of pyrazolopyrimidine derivatives targeting Janus kinase 3 (JAK3)
Abdelmoujoud Faris, Ivana Cacciatore, Radwan Alnajjar, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
The role of proteolysis in interleukin-11 signaling
Juliane Lokau, Birte Kespohl, Sophia Kirschke, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2021) Vol. 1869, Iss. 1, pp. 119135-119135
Open Access | Times Cited: 17
IL10- and IL35-Secreting MutuDC Lines Act in Cooperation to Inhibit Memory T Cell Activation Through LAG-3 Expression
Marianna M. Koga, Adrien Engel, Matteo Pigni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 15
Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Chrong‐Reen Wang, Hung‐Wen Tsai
World Journal of Diabetes (2021) Vol. 12, Iss. 3, pp. 238-260
Open Access | Times Cited: 15
Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib
Qian Xing, Zhongwei Zhang, Biao Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease
Arezoo Hosseini, Zohreh Babaloo, Tohid Gharibi, et al.
BMC Research Notes (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 15
QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors
Abdelmoujoud Faris, Ibrahim M. Ibrahim, Radwan Alnajjar, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-30
Open Access | Times Cited: 5
Upadacitinib protects against cisplatin-induced renal and hepatic dysfunction without impairing its anticancer activity
Hanan S. Anbar, Naglaa Gamil Shehab, Nadia M.M. El-Rouby, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 172, pp. 106149-106149
Open Access | Times Cited: 8
The Mutational Landscape of Myeloid Leukaemia in Down Syndrome
Carini Picardi Morais de Castro, Maria Cadefau, Sergi Cuartero
Cancers (2021) Vol. 13, Iss. 16, pp. 4144-4144
Open Access | Times Cited: 11
STAT3 single-nucleotide variants in autoimmune thyroid disease in the Pakhtun population of Khyber Pakhtunkhwa, Pakistan
Khayyam Khan, Muhammad Zahid, Niaz Ali, et al.
Gene Reports (2024) Vol. 36, pp. 101950-101950
Closed Access | Times Cited: 1
Clinical pharmacokinetic characteristics of Jaktinib in subjects with hepatic impairment in a phase I trial
Man-Na Zhao, Hua Zhang, Sheng Ma, et al.
Drug Metabolism and Pharmacokinetics (2024) Vol. 59, pp. 101030-101030
Closed Access | Times Cited: 1
BCL2L15 Depletion Inhibits Endometrial Receptivity via the STAT1 Signaling Pathway
Diqi Yang, Liu Ai, Yanqin Wu, et al.
Genes (2020) Vol. 11, Iss. 7, pp. 816-816
Open Access | Times Cited: 11
Intrinsic drug potential of oxazolo[5,4‐d]pyrimidines and oxazolo[4,5‐d]pyrimidines
Victor Zhirnov, Yevheniia Velihina, Oleg P. Mitiukhin, et al.
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 4, pp. 561-581
Closed Access | Times Cited: 10
COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends
Komal Thapa, Nitin Verma, Thakur Gurjeet Singh, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108328-108328
Open Access | Times Cited: 10

Scroll to top